148 related articles for article (PubMed ID: 16893996)
1. The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice.
Mujtaba MG; Patel CB; Patel RA; Flowers LO; Burkhart MA; Waiboci LW; Martin J; Haider MI; Ahmed CM; Johnson HM
Clin Vaccine Immunol; 2006 Aug; 13(8):944-52. PubMed ID: 16893996
[TBL] [Abstract][Full Text] [Related]
2. Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.
Ahmed CM; Burkhart MA; Subramaniam PS; Mujtaba MG; Johnson HM
J Virol; 2005 May; 79(9):5632-9. PubMed ID: 15827178
[TBL] [Abstract][Full Text] [Related]
3. IFN mimetic as a therapeutic for lethal vaccinia virus infection: possible effects on innate and adaptive immune responses.
Ahmed CM; Martin JP; Johnson HM
J Immunol; 2007 Apr; 178(7):4576-83. PubMed ID: 17372016
[TBL] [Abstract][Full Text] [Related]
4. Role of trehalose dimycolate-induced interferon-alpha/beta in the restriction of encephalomyocarditis virus growth in vivo and in peritoneal macrophage cultures.
Guillemard E; Geniteau-Legendre M; Kergot R; Lemaire G; Petit JF; Labarre C; Quero AM
Antiviral Res; 1995 Oct; 28(2):175-89. PubMed ID: 8585770
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice.
Hirasawa K; Ogiso Y; Takeda M; Lee MJ; Itagaki S; Doi K
Lab Anim Sci; 1995 Dec; 45(6):652-6. PubMed ID: 8746525
[TBL] [Abstract][Full Text] [Related]
6. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
[TBL] [Abstract][Full Text] [Related]
7. The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon.
Ozmen L; Aguet M; Trinchieri G; Garotta G
J Virol; 1995 Dec; 69(12):8147-50. PubMed ID: 7494339
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by muramyl peptides of the protective response of interferon-alpha/beta against encephalomyocarditis virus infection.
Pouillart PR; Audibert FM; Chedid LA; Lefrancier PL; Bahr GM
Int J Immunopharmacol; 1996 Mar; 18(3):183-92. PubMed ID: 8796446
[TBL] [Abstract][Full Text] [Related]
9. The Intestinal Microbiome Primes Host Innate Immunity against Enteric Virus Systemic Infection through Type I Interferon.
Yang XL; Wang G; Xie JY; Li H; Chen SX; Liu W; Zhu SJ
mBio; 2021 May; 12(3):. PubMed ID: 33975932
[TBL] [Abstract][Full Text] [Related]
10. The significance of T cells, B cells, antibodies and macrophages against encephalomyocarditis (EMC)-D virus-induced diabetes in mice.
Kounoue E; Izumi K; Ogawa S; Kondo S; Katsuta H; Akashi T; Niho Y; Harada M; Tamiya S; Kurisaki H; Nagafuchi S
Arch Virol; 2008; 153(7):1223-31. PubMed ID: 18500429
[TBL] [Abstract][Full Text] [Related]
11. In vivo antiviral activity of recombinant murine gamma interferon.
Shalaby MR; Hamilton EB; Benninger AH; Marafino BJ
J Interferon Res; 1985; 5(2):339-45. PubMed ID: 2989389
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction mechanism of a peptide mimetic of interferon-gamma.
Subramaniam PS; Flowers LO; Haider SM; Johnson HM
Biochemistry; 2004 May; 43(18):5445-54. PubMed ID: 15122910
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.
Ahmed CM; Dabelic R; Martin JP; Jager LD; Haider SM; Johnson HM
J Immunol; 2010 Jul; 185(2):1103-13. PubMed ID: 20543109
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.
Lee YS; Li N; Shin S; Jun HS
J Virol; 2009 Aug; 83(16):8004-11. PubMed ID: 19535454
[TBL] [Abstract][Full Text] [Related]
15. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta.
Sato K; Hida S; Takayanagi H; Yokochi T; Kayagaki N; Takeda K; Yagita H; Okumura K; Tanaka N; Taniguchi T; Ogasawara K
Eur J Immunol; 2001 Nov; 31(11):3138-46. PubMed ID: 11745330
[TBL] [Abstract][Full Text] [Related]
16. Innate immune response to encephalomyocarditis virus infection mediated by CD1d.
Exley MA; Bigley NJ; Cheng O; Shaulov A; Tahir SM; Carter QL; Garcia J; Wang C; Patten K; Stills HF; Alt FW; Snapper SB; Balk SP
Immunology; 2003 Dec; 110(4):519-26. PubMed ID: 14632651
[TBL] [Abstract][Full Text] [Related]
17. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses.
Venkataraman T; Valdes M; Elsby R; Kakuta S; Caceres G; Saijo S; Iwakura Y; Barber GN
J Immunol; 2007 May; 178(10):6444-55. PubMed ID: 17475874
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.
Sonnenfeld G; Tovey M; Schellekens H; Kinney KS; Belay T; Morton DS; Austin CE; Reitman M; Fong TA; Vaughan HS
J Interferon Cytokine Res; 2001 Jul; 21(7):539-45. PubMed ID: 11506749
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of testicular lesions in mice infected with a low dose of encephalomyocarditis (EMC) virus.
Yamanouchi-Ueno A; Nakayama Y; Doi K
Exp Mol Pathol; 2004 Aug; 77(1):72-6. PubMed ID: 15215053
[TBL] [Abstract][Full Text] [Related]
20. The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site.
Subramaniam PS; Larkin J; Mujtaba MG; Walter MR; Johnson HM
J Cell Sci; 2000 Aug; 113 ( Pt 15)():2771-81. PubMed ID: 10893192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
